z-logo
open-access-imgOpen Access
Chlamydial Genovar Distribution after Communitywide Antibiotic Treatment
Author(s) -
Deborah L. Bain,
Thomas M. Lietman,
Stephanie Rasmussen,
Sue Kalman,
Jun Fan,
C. J. Lammel,
J Zhang,
Chandler R. Dawson,
Julius Schachter,
Richard S. Stephens
Publication year - 2001
Publication title -
the journal of infectious diseases
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/324661
Subject(s) - trachoma , azithromycin , chlamydia , tetracycline , epidemiology , antibiotics , chlamydia trachomatis , medicine , biology , virology , microbiology and biotechnology , immunology , pathology
Major outer membrane protein sequences, determined from Chlamydia-positive eye swab samples collected in 2 Egyptian villages, were used to analyze the epidemiology of trachoma in an endemic setting. Samples were collected during the 1999 Azithromycin in Control of Trachoma trial, in which residents of villages were mass treated with either oral azithromycin or topical tetracycline and were followed up for nearly 2 years. Three genovar families (A, Ba, and C) and 12 genovars were detected, with 2 genovars (A1 and Ba1) comprising almost 75% of the samples. The presence of >1 genovar within households was common, with > or =24% of households having >1 genovar. Evidence consistent with reinfection and persistence as mechanisms of communitywide continued presence of trachoma was provided by data for individuals infected with rare genovars.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom